Overview
- 117 inspections across 116 sites are on record.
- 352 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-11-17.
At a glance
Inspections
117
Sites
116
Observations
352
Career since
Apr 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Laboratorios Zepol S.A. | 17 Nov 2023 | Human Drugs | View 483 → |
| ALS Pharma Ltda | 8 Nov 2023 | Human Drugs | View 483 → |
| BCQ Consultoria e Qualidade Sociedade Simples Ltda. | 1 Nov 2023 | Human Drugs | On file |
| Jiangsu NHWA Pharmaceutical Co., Ltd. | 1 Sep 2023 | Human Drugs | On file |
| Gland Pharma Limited | 14 Jul 2023 | Human Drugs | View 483 → |
Sites inspected
Laboratorios Zepol S.A.Curridabat, Costa Rica1 insp.
ALS Pharma LtdaPaulinia, Brazil1 insp.
BCQ Consultoria e Qualidade Sociedade Simples Ltda.Sao Paulo, Brazil1 insp.
Jiangsu NHWA Pharmaceutical Co., Ltd.Xuzhou, China1 insp.
Gland Pharma LimitedHyderabad, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Roger F Zabinski3 shared
Linda F Murphy3 shared
Djamila Harouaka3 shared
Charanjeet Jassal3 shared
Youkeun Kim2 shared
Kevin P Regan2 shared
Santos E Camara2 shared
Pratik S Upadhyay2 shared
Liming Zhang2 shared
Daniel J Roberts2 shared
Full investigator report
Get the verbatim findings behind Alan P Kurtzberg's 352 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site